ArticleFrontiers in cellular and infection microbiology2026
Clinical epidemiology and associations between HPV infection and vaginal infections in Jinan, China: a cross-sectional analysis.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the principal cause of cervical cancer, human papillomavirus (HPV) infection is linked to vaginal infections such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), aerobic vaginitis (AV), and Methods: In this study, we performed a cross-sectional analysis of 10,104 women in Jinan, China, to establish a detailed association between HPV and vaginal infections. Results: Our analysis showed that the HPV infection rate in Jinan was 21.84% of which the high-risk HPV (HR-HPV) infection rate was 84.32%. Although HR-HPV, low-risk HPV, BV, VVC, and TV prevalence rates across seasons were not statistically significant, we discerned significance for AV. In addition, while there was no difference between the prevalence of HPV and VVC, women with BV, AV, TV, or any vaginal infection manifested a higher risk of HPV infection. As for HR-HPV, our results showed statistically significant differences in HR-HPV infection rates between patients with BV, AV, TV, or any type of vaginal infection and the control group; however, VVC cases and cases without VVC did not differ. Furthermore, our correlation analysis among different HR-HPV genotypes and vaginal infections revealed an elevated incidence of BV in individuals with HPV45, HPV51, HPV52, HPV58, HPV66, and HPV68. AV exhibited an elevated infection rate in women with HPV16, HPV33, and HPV68; while TV demonstrated an increased infection risk in women with HPV52. Conclusion: We hereby explored the complex relationship between HPV infection and vaginal infections and provided information on early-detection, preventive, and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.